NYSE:VEEV#2 of 7 in this industry2 markets
Veeva
provide identity management software and datacrossing the boundaries between mdmdata quality and data broker.
Revenue$3.2Bfrom a sourced record
Markets named in2across this research
Incumbent in2the one to displace
Rank in industry2 / 7by revenue
01
Where it competes
Every market in this research that names Veeva. Where it is the named incumbent it leads the list. The entry signal is the market’s, not the company’s — it says how open that market is to someone new.
| Market | Role | Share | Entry signal |
|---|---|---|---|
| Life Sciences Commercial Software 3254 Pharmaceutical and medicine manufacturing |
Incumbent | — | 32% entry signal |
| Clinical Trial & R&D Data Management Software 5417 Scientific research and development services |
Incumbent | — | 32% entry signal |
02
Others in Pharmaceutical and medicine manufacturing
Ranked by revenue. Companies that disclose none follow, ordered by how many markets name them.
| 1 | IQVIA NYSE:IQV | $6.6B |
| 2 | Veeva NYSE:VEEV | $3.2B |
| 3 | AcuityMD Private | — |
| 4 | Certara Private | — |
| 5 | Definitive Healthcare Private | — |
| 6 | Komodo Health Private | — |
| 7 | Salesforce Life Sciences Cloud Private | — |
Company details are from the search.cos database (snapshot 2026-10-10); market roles, shares and sourced revenue are from the research records linked above. Filed under the industry it serves — a software vendor sits with the industry that buys from it. Ranks convert currencies at approximate rates to put companies in order; every figure shown is in the currency it was reported in.